New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

Long COVID and cardiovascular disease: a learning health system approach

COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study

Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis - ScienceDirect

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial - eBioMedicine

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial - The Lancet Respiratory Medicine

Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

Penn Study Finds Serotonin Reduction Causes Long COVID Symptoms